Universal treatment of multidrug-resistant TB is possible within current budgets with generic production
Polly Clayden
Aug. 3, 2016, 1:03 p.m.
Generic production could make novel multidrug-resistant tuberculosis (MDR-TB) regimens available for US $53–507 per treatment course according to data presented at TB2016.